Full access
Health Care Economics
Published Online: 15 May 2009

Price of Brand-Name Psychiatric Drugs on Steep Upward Course

Mark MoranAuthors Info & Affiliations
Publication: Psychiatric News
Volume 44, Number 10
https://doi.org/10.1176/pn.44.10.0022a
Manufacturer prices for brand-name prescription drugs widely used by Medicare beneficiaries jumped by nearly 9 percent in 2008, according to the 2009 AARP “Rx Watchdog Report.”
That increase was the largest annual increase in six years and greatly exceeded the general inflation rate of 3.8 percent.
Major classes of psychiatric brand-name drugs—including antidepressants, antipsychotics, sedatives, antidementia agents—experienced price increases that exceeded general inflation. Grouped in a class and compared with all other therapeutic drug categories, two dosages of Wellbutrin (300 mg and 150 mg) experienced the greatest increase, rising in price by 21 percent (see chart).
Meanwhile, manufacturer prices of widely used generic drugs continued to decrease in 2008, falling by an average of 10.6 percent. The majority of generics (83 percent) did not change in price in 2008, despite an increase in general inflation.
And some of the generics that did drop in price did so very dramatically. For instance, the manufacturer price for the brand-name antidepressant Zoloft (50 mg and 100 mg tablets) increased by 12.3 percent in 2008, but the price for generic sertraline made by Teva Pharmaceuticals decreased by 45.1 percent, according to the report.
“A person taking three brand-name prescription drugs could see his or her annual costs climb by more than $550 in just one year,” AARP Public Policy Director John Rother said in a statement released with the report.“ Switching to generic drugs whenever possible is one of the quickest and easiest ways to drastically reduce health care bills.”
The list of prescription drugs widely used by Medicare beneficiaries is based on the 300 most widely dispensed drug products, the 300 drug products with the highest sales levels, and the 300 drug products with the highest number of days of therapy among the prescriptions provided by United Healthcare-PacificCare. (That company provides Medicare Part D coverage and is also the organization that insures the AARP Medicare Rx Plans.)
Price changes were measured using changes in the wholesale acquisition cost as published by the Medi-Span Price-Chek PC Database.
AARP's “Rx Watchdog Report” is posted at<http://assets.aarp.org/rgcenter/health/2009_07_rxq408.pdf>.▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 44 • Number 10 • May 15, 2009
Pages: 22

History

Published online: 15 May 2009
Published in print: May 15, 2009

Notes

Brand name antidepressants, antipsychotics, sedatives, and antidementia agents all experienced manufacturer price increases that exceeded general inflation.

Authors

Affiliations

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.